I wouldn't, Fred, but their product is still fledgeling and they are still signing new partners for it. The bigger problem with this pinksheet and many others is the shorting of it, selling of shares from preferred and restricted holders, and convertible debt in shares being dumped, hence the huge drop in pps this year. Unfortunately, this stock may keep bleeding. Watching from a safe distance.
News 
Market Data 
Discover 
